LEXEO THERAPEUTICS

lexeo-therapeutics-logo

LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. Beyond LEXEO Therapeutics’ lead programs – which are focused on both rare and non-rare monogenic (single genemutation) diseases – the company’s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum o... f patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine’s Department of Genetic Medicine to help advance the company’s pre-clinical pipeline.

#SimilarOrganizations #People #Financial #Website #More

LEXEO THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2018-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.lexeotx.com

Total Employee:
11+

Status:
Active

Contact:
(212) 547-9879

Email Addresses:
info@lexeotx.com

Total Funding:
185 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache


Similar Organizations

accent-therapeutics-logo

Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company.

asgard-therapeutics-logo

Asgard Therapeutics

Asgard Therapeutics is a Biotechnology Company.

curasen-therapeutics-logo

CuraSen Therapeutics

CuraSen Therapeutics is a biopharmaceutical company.

cygnal-therapeutics-logo

Cygnal Therapeutics

Cygnal Therapeutics is a biotechnology company

emendo-biotherapeutics-logo

Emendo Biotherapeutics

Emendo Biotherapeutics is a biotechnology company

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

faze-medicines-logo

Faze Medicines

Faze Medicines is a biotechnology company.

immunicom-logo

Immunicom

Immunicom is a biotechnology company.

libra-therapeutics-logo

Libra Therapeutics

Libra Therapeutics is a biotechnology company.

moma-therapeutics-logo

MOMA Therapeutics

MOMA Therapeutics operates as a biotechnology company.

primmune-therapeutics-logo

Primmune Therapeutics

Primmune Therapeutics is a Biotechnology company.

not_available_image

Rekindle Therapeutics

Rekindle Therapeutics is a biotechnology company.

terray-therapeutics-logo

Terray Therapeutics

Terray Therapeutics is a biotechnology company.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

xios-therapeutics-logo

Xios Therapeutics

Xios Therapeutics is a biotechnology company .


Current Advisors List

sandip-agarwala_image

Sandip Agarwala Board Member @ LEXEO Therapeutics
Board_member
2020-11-07

mette-kirstine-agger_image

Mette Kirstine Agger Board Member @ LEXEO Therapeutics
Board_member
2021-01-07

bernard-davitian_image

Bernard Davitian Board Member @ LEXEO Therapeutics
Board_member
2021-01-07

Current Employees Featured

ronald-g-crystal_image

Ronald G. Crystal
Ronald G. Crystal Founder, Chief Scientific Advisor & Board Observer @ LEXEO Therapeutics
Founder, Chief Scientific Advisor & Board Observer

r-nolan-townsend_image

R. Nolan Townsend
R. Nolan Townsend CEO @ LEXEO Therapeutics
CEO
2020-01-01

Founder


ronald-g-crystal_image

Ronald G. Crystal

Acquisitions List

Date Company Article Price
2021-07-21 Stelios Therapeutics Stelios Therapeutics acquired by LEXEO Therapeutics N/A

Investors List

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - LEXEO Therapeutics

gray-s-creek-capital-partners_image

Gray’s Creek Capital Partners

Gray’s Creek Capital Partners investment in Series B - LEXEO Therapeutics

omega-funds_image

Omega Funds

Omega Funds investment in Series B - LEXEO Therapeutics

eventide-asset-management_image

Eventide

Eventide investment in Series B - LEXEO Therapeutics

verition-fund-management_image

Verition Fund Management

Verition Fund Management investment in Series B - LEXEO Therapeutics

laurion-capital-management_image

Laurion Capital Management

Laurion Capital Management investment in Series B - LEXEO Therapeutics

intus-capital_image

Intus Capital

Intus Capital investment in Series B - LEXEO Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - LEXEO Therapeutics

camcapital_image

CAM Capital

CAM Capital investment in Series B - LEXEO Therapeutics

d1-capital-partners_image

D1 Capital Partners

D1 Capital Partners investment in Series B - LEXEO Therapeutics

Official Site Inspections

http://www.lexeotx.com Semrush global rank: 528.08 K Semrush visits lastest month: 91.71 K

  • Host name: vps34638.dreamhostps.com
  • IP address: 67.205.19.65
  • Location: Brea United States
  • Latitude: 33.9339
  • Longitude: -117.8854
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 92821

Lexeotx.com lookup results from whois.squarespace.domains server:
  • Domain created: 6th-Nov-2019
  • Domain updated: 22nd-Oct-2024
  • Domain expires: 6th-Nov-2025 0 Years, 204 Days left
  • Website age: 5 Years, 161 Days
  • Registrar Domain ID: 2452069311_DOMAIN_COM-VRSN
  • Registrar Url: http://domains2.squarespace.com
  • Registrar WHOIS Server: whois.squarespace.domains
  • Registrar Abuse Contact Email: abuse-complaints@squarespace.com
  • Registrar Abuse Contact Phone: +1.6466935324
  • Name server:
    • NS1.DREAMHOST.COM
    • NS2.DREAMHOST.COM

More informations about "LEXEO Therapeutics" on Search Engine